Illustration: Radina Dobrinova for Endpoints News

Rav­gen con­tin­ues its le­gal re­venge saga with a $57M ver­dict over Nat­era

Rav­gen, a com­pa­ny that was a blip in pre­na­tal screen­ing not long ago, has con­tin­ued its streak of le­gal vic­to­ries against much larg­er com­pa­nies thanks …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA